Pharmaceutical Research Associates, Inc. competitors

Zippia score 4.6

Pharmaceutical Research Associates, Inc. main competitors are Cytel, Vertex Pharmaceuticals, and Parexel International.

Competitor Summary. See how Pharmaceutical Research Associates, Inc. compares to its main competitors:

Covance has the most employees (50,000).
Employees at Cytel earn more than most of the competitors, with an average yearly salary of $104,401.
The oldest company is BASi, founded in 1974.

Work at Pharmaceutical Research Associates, Inc.?

Share your experience

Pharmaceutical Research Associates, Inc. vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Pharmaceutical Research Associates, Inc.	1981	4.6	Reston, VA	1	$30.0M	30
Cytel	1987	4.5	Cambridge, MA	2	$49.9M	1,000
Parexel International	1983	4.5	Waltham, MA	9	$2.4B	18,900
Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$11.0B	3,400
Biorasi	2002	4.2	Hollywood, FL	2	$23.0M	750
Medpace	1992	4.5	Cincinnati, OH	3	$2.1B	2,800
Covance	1987	4.4	Princeton, NJ	25	$2.6B	50,000
Pharmaceutical Product Development	1985	4.1	Wilmington, NC	13	$65.0M	21,000
Novella	1998	4.2	Morrisville, NC	1	$9.2M	3,000
BASi	1974	4.0	West Lafayette, IN	3	$23.5M	421
Axio Research	1979	3.8	Seattle, WA	1	$5.4M	50
Achillion Pharmaceuticals	1998	3.8	New Haven, CT	1	$15.0M	56
Abraxis BioScience	2007	4.5	Los Angeles, CA	1	$359.0M	885
Chiltern	1982	4.3	Wilmington, NC	1	$3.1M	35

Rate how well Pharmaceutical Research Associates, Inc. differentiates itself from its competitors.

Pharmaceutical Research Associates, Inc. salaries vs competitors

Among Pharmaceutical Research Associates, Inc. competitors, employees at Cytel earn the most with an average yearly salary of $104,401.

Compare Pharmaceutical Research Associates, Inc. salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Pharmaceutical Research Associates, Inc.	$77,178	$37.10	-
Cytel	$104,401	$50.19	-
Parexel International	$91,480	$43.98	-
Vertex Pharmaceuticals	$95,952	$46.13	-
Biorasi	$69,796	$33.56	-
Medpace	$69,547	$33.44	-

Compare Pharmaceutical Research Associates, Inc. job title salaries vs competitors

Company	Highest salary	Hourly salary
Pharmaceutical Research Associates, Inc.	$97,202	$46.73
Vertex Pharmaceuticals	$116,184	$55.86
BASi	$101,612	$48.85
Parexel International	$98,693	$47.45
Axio Research	$96,696	$46.49
Achillion Pharmaceuticals	$96,036	$46.17
Cytel	$95,816	$46.07
Novella	$95,662	$45.99
Pharmaceutical Product Development	$92,919	$44.67
Medpace	$92,394	$44.42
Biorasi	$92,333	$44.39
Chiltern	$89,524	$43.04
Abraxis BioScience	$84,188	$40.48
Covance	$82,546	$39.69

Do you work at Pharmaceutical Research Associates, Inc.?

Is Pharmaceutical Research Associates, Inc. able to compete effectively with similar companies?

Pharmaceutical Research Associates, Inc. jobs

Pharmaceutical Research Associates, Inc. demographics vs competitors

Compare gender at Pharmaceutical Research Associates, Inc. vs competitors

Job title	Male	Female
Medpace	33%	67%
Parexel International	40%	60%
BASi	47%	53%
Achillion Pharmaceuticals	50%	50%
Vertex Pharmaceuticals	56%	44%
Pharmaceutical Research Associates, Inc.	-	-

Male

Female

100%

75%

50%

25%

Pharmaceutical Research Associates, Inc.

Vertex Pharmaceuticals

Achillion Pharmaceuticals

BASi

Parexel International

Medpace

25%

50%

75%

100%

Compare race at Pharmaceutical Research Associates, Inc. vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Achillion Pharmaceuticals	61%	13%	6%	17%	2%	6.4
BASi	67%	10%	11%	9%	3%	7.4
Medpace	66%	11%	8%	12%	3%	9.5
Parexel International	57%	13%	11%	15%	5%	9.8
Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7
Covance	59%	14%	11%	12%	4%	9.9

Pharmaceutical Research Associates, Inc. and similar companies CEOs

CEOBio

Milind Deshpande

Achillion Pharmaceuticals

Milind Deshpande is a President and Chief Executive Officer at ACHILLION PHARMACEUTICALS INC and is based in United States.

Brian R. Bond

BASi

August J. Troendle M.D.

Medpace

August Troendle is a Chairman/President/CEO/Founder at Medpace and is based in Ohio. He has worked as Board Member at Xenon Pharmaceuticals Inc. and Board Member at COHERUS BIOSCIENCES, INC.. August studied at University of Maryland.

Jamie MacDonald

Parexel International

Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies. Prior to joining Parexel, Mr. Macdonald served as CEO of INC Research, now known as Syneos Health, from January 2013 through September 2016, where he led the company through a successful Initial Public Offering in 2014. Mr. Macdonald also served as INC’s Chief Operating Officer from July 2011 through December 2012, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this, he held various senior operational and finance roles at Quintiles. He has previously served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and as its Chairman in 2015. Mr. Macdonald’s recent experience also includes serving as Chairman of the Board for Certara, a drug development consultancy with solutions spanning discovery, preclinical and clinical drug development, from 2017 to 2018. Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Paul Kirchgraber

Covance

Paul Kirchgraber is a CEO at Covance.

Richard Staub

Novella

David Simmons

Pharmaceutical Product Development

Mark Penniston

Chiltern

Chris O’Brien

Biorasi